1-2/06/2016 - Seminar: “From Biosamples to Personalized Medicine” (Belgium)

On 31 May 2016, BBMRI-ERIC will be organising a seminar which aims to explore and better understand the potential contribution of the activities that BBMRI-ERIC is undertaking towards the achievement of the proposed roadmap for personalized medicine.

BBMRI-ERIC is key biomolecular and medical research infrastructure providing access to valuable biological samples and data, which is a prerequisite for innovative, efficient, and sustainable health systems. Personalized medicine is moving away from the “one size fits all” approach of treatment towards an approach tailored to the patient or a group of patients – for prevention, prediction and treatment, addressing the challenges of an ageing population, and the related increase in chronic and complex diseases.

The European Commission will organise on 1-2 June 2016 the Personalized Medicine Conference 2016 which will explore personalized medicine through a research policy lens, focusing, inter alia, on awareness, integrating ICT solutions, clinical research, innovation, and sustainable healthcare.

BBMRI-ERIC is organizing a side seminar, which is to take place on 31 May 2016 and aims to explore and better understand the potential contribution of the activities BBMRI-ERIC undertakes to the achievement of the proposed roadmap for personalized medicine. Entitled “From Biosamples to Personalized Medicine” the seminar will examine how increased access to biomolecular material will enable progress to personalized medicine, while recognizing the future impact of the General Data Protection Regulation and the potential offered by the European Union’s Open Science Cloud and related data health systems. Furthermore, the global dimension will also be examined through related initiatives in Africa and potential for a long-term collaboration with Africa in biobanking cooperation and the shared resource this will provide for advancement of health systems in the developing nations.

The seminar will bring together the research community, academia, stakeholders, industry, and policy-makers for a discussion on the role of biobanking in personalized medicine, the potential of the big data and related issues, and policy challenges ahead. The seminar will also highlight the industry and stakeholders’ perspective and some key national initiatives.

The detailed programme will be uploaded shortly.
Event venue: Rue de la Science 14b, Brussels.

Read More:
“From Biosamples to Personalized Medicine”